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Objective(s): Methylsulfonylmethane (MSM) is a sulfur-containing compound found in a wide 
range of human foods including fruits, vegetables, grains and beverages. In this study the effect of 
MSM pretreatment on acetaminophen induced liver damage was investigated.  
Materials and Methods: Male Sprague Dawley rats were pretreated with 100 mg/kg MSM for one 
week. On day seven rats were received acetaminophen (850 mg/kg, intraperitoneal). Twenty-four 
hours later, blood samples were taken to determine serum aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT). Tissue samples of liver were also taken for the determination of 
the levels of malondialdehyde (MDA); total glutathione (GSH), superoxide dismutase (SOD), and 
myeloperoxidase (MPO) activity together with histopathological observations.  
Results: High dose of acetaminophen administration caused a significant decrease in the GSH level 
of the liver tissue, which was accompanied with a decrease in SOD activity and increases in tissue 
MDA level and MPO activity. Serum ALT, AST levels were also found elevated in the 
acetaminophen-treated group. Pretreatment with MSM for one week was significantly attenuated 
all of these biochemical indices. 
Conclusion: Our findings suggest that MSM pretreatment could alleviate hepatic injury induced by 
acetaminophen intoxication, may be through its sulfur donating and antioxidant effects.  
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Introduction 
Methylsulfonylmethane (MSM) is a sulfur-
containing compound found in a wide range of human 
foods including fruits, vegetables, grains, and beverages 
(1). Recently, the anti-inflammatory effect of MSM on 
lipopolysaccharide-induced inflammatory responses 
have been shown in murine macrophages (2) and on 
experimental colitis in rats (3). Nevertheless, the effects 
of anti-oxidant of MSM on pitting edema (4) and 
exercise induced oxidative stress have been reported 
(5). It was reported that MSM may be used as a 
precursor for the synthesis of methionine and cysteine, 
sulfur containing amino acids, and act as a source of 
sulfur (6).  
In previous studies it has been shown that MSM is 
relatively non-toxic compound (7). In addition, some 
investigations have reported  that MSM did not cause 
any adverse side effects or increased mortality (8, 9). 
Kim et al have also depicted that MSM may cause side 
effects not more than the placebo (10). 
Acetaminophen (APAP) is a safe, effective and 
widely used analgesic–antipyretic drug. However, an 
overdose can induce severe hepatotoxicity (11). Recent 
evidences suggest that reactive metabolite formation 
and glutathione depletion is some of the initiating 
events for its toxicity (12).  
Considering the underlying mechanisms of 
acetaminophen induced liver injury and sulfur donating; 
free radical lowering effect of MSM, it seems that 
premedication with MSM may prevent hepatotoxicity 
associated with acetaminophen overdose.  
Our previous studies showed that single and acute 
administration of MSM does not exert a significant 
increase on plasma GSH level (13), however; in chronic 
and pretreatment mode it is able to produce significant 
increase in plasma GSH level (14). Therefore, the 
present work was undertaken as a pilot study to 
examine the potential protective effect of MSM 
pretreatment against acetaminophen induced 
hepatotoxicity in rats.  
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Materials and Methods  
Chemicals 
Methylsulfonylmethane and Acetaminophen was 
used in this study (Sigma-Aldrich Chemicals). All 
other chemicals were of analytical grade. 
 
Experimental animal and design 
Twenty four pathogen-free male Sprague Dawley 
rats (four weeks) were obtained f (Animal Center, 
Pasture Institute, Iran). Rats were then housed in 
specific standard laboratory conditions for one week. 
All animals were kept in a temperature-controlled 
environment (25 ± 1 °C), a relative humidity (70 ± 
5%), and were fed with standard rat chow diet and 
water ad libitum. Rats weighting in the range of 190–
220 g were used for induction of APAP-induced 
hepatotoxicity. All rats were received humane care in 
accordance to the “Guide for the Care and Use of 
Laboratory Animals” (National Academies Press, 
Washington, DC, USA, 1996). 
The experiment was conducted according to the 
procedures described previously (15). Acetaminophen 
was dissolved in 40% polyethylene glycol 400 for 
intraperitoneal (IP) administration. For all groups, the 
time interval between first and second administration 
at day seven was 30 min. Rats were randomly divided 
into four groups, each consisting of six rats. Group 1 
served as normal control and received 1 ml/kg isotonic 
0.9% NaCl IP daily for seven days, and then injected IP 
with 10 ml/kg isotonic 0.9% NaCl, at day seven. Group 
2 served as hepatotoxicity control and received 1ml/kg 
isotonic 0.9% NaCl IP daily for seven days, and at the 
day seven were intoxicated with 835 mg/kg 
acetaminophen IP. Group 3 used as MSM control and 
received 100 mg/kg MSM IP in water daily for seven 
days and then injected with 10 ml/kg isotonic 0.9% 
NaCl IP. Group 4 was received 100 mg/kg MSM IP in 
water daily for seven days and at day seven intoxicated 
with 835 mg/kg acetaminophen IP. After 24 hr of 
acetaminophen intoxication, rats were euthanized by 
ether and then sacrificed.  Blood sample was collected 
by cardiac puncture in heparinized tubes. The liver was 
immediately taken out and washed with ice-cold saline, 
then weighed and stored at −80 °C. The blood and liver 
samples were then assessed for their biochemical 
indices. A piece of liver was finally fixed in formalin to 
examine histopathological changes.  
 
Measurement of liver function markers 
The whole blood was centrifuged at 3000 rpm for 
10 min to separate the plasma. Markers of liver 
function including AST and ALT were measured with 
colorimetric methods using commercially available 
kits (Zist-Shimi Co, Tehran, Iran) by double beam 
spectrophotometer (T80+, PG-Instruments, UK). 
 
Measurement of antioxidant enzymes and lipid 
peroxidation 
Liver tissues were homogenized in four volumes of 
ice-cold 150 mM Tris–HCl (pH 7.4) using Hiedolph 
homogenizer (SilentCrush M, Hiedolph, Germany). 
The homogenates were centrifuged at 16000 g for 
15 min at 4C to obtain a supernatant for various 
biochemical analyses. Lipid peroxidation in the liver 
homogenate was determined by the formation of 
MDA and was measured as reported previously (14). 
The data are expressed in nanomolar (nmol) of MDA 
per milligram of liver tissue (nmol/mg tissue). Liver 
Total GSH and SOD were determined as markers of 
anti-oxidant capacity using commercially available 
kits (Cayman, USA) and described in concentrations 
were expressed as nmol of total GSH per mg tissue. 
SOD activity was stated as units per mg tissue. MPO 
activity was then measured using commercially 
available kits (Cayman, USA) as index of neutrophil 
infiltration to liver tissue and considered as marker 
of inflammation and oxidative stress and expressed 
as units per mg tissue. 
 
Histopathological observation 
The liver tissues were fixed in 10% formalin 
buffer solution for 24 hr embedded in paraffin. The 
serial sections were cut 5 m thick and stained with 
haematoxylin-eosin (HE), and then observed for the 
changes of liver injury by photomicroscope. 
 
Statistical analysis 
All data were expressed as means ± standard 
deviations. Statistical analysis was performed using 
one-way ANOVA followed by Tukey test. P< 0.05 was 
considered significant.  
 
Results  
There is an increase in the levels of AST and ALT 
in the blood, which reflects the failure of liver 
function due to APAP-induced hepatotoxicity. In 
Figure 1, AST and ALT activities were significantly 
increased after the administration of APAP as 
compared with the normal group (P< 0.001). 
Although pretreatment with 100 mg/kg of MSM for 
one week significantly blunted the elevation of AST 
and ALT (P< 0.001), the serum value of ALT was still 
significantly higher than the normal group. 
It was found that liver MDA level was significantly 
higher in APAP intoxicated group comparing with 
normal group (P< 0.05). Pretreatment with MSM 
was able to prevent MDA elevation (P< 0.01). 
Compared with the normal group, hepatic MPO 
activity was increased significantly in the group who 
received acetaminophen (P< 0.01), indicating the 
increase in neutrophil infiltration to the tissue (Table 
1). This elevation in the myeloperoxidase activity 
which induced by acetaminophen was significantly 
attenuated with MSM pretreatment (P < 0.05). 
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Table 1. Effect of pretreatment with MSM on liver function markers in rats with acetaminophen-induced hepatotoxicity 
 
Treatment MDA (nmol/mg tissue) Total GSH (nmol/mg tissue) SOD (U/mg tissue) MPO (U/mg tissue) 
Normal 5.01±0.59++ 33.55±4.88++ 1.4±0.1+ 2.1±0.5+ 
APAP 8.29±2.26* 10.58±0.89* 0.8±0.2* 4.3±0.9* 
MSM 100 mg 3.64±0.69++ 36.03±6.19++ 1.5±0.4+ 2.8±1.0+ 
MSM 100 mg + APAP 4.54±1.67++ 20.94±1.82++* 1.6±0.5+ 2.6±0.5+ 
 
MSM: Methylsulfonylmethane; MDA: Malondialdehyde; GSH: Total glutathione; SOD: Superoxide dismutase; MPO: Myeloperoxidase  
Values were expressed as mean ± SD, n=6. APAP: acetaminophen 
* P < 0.05 significantly different from normal group 
++ P< 0.01 significantly different from APAP control group 
+ P< 0.05 significantly different from APAP control group 
 
 
 
 
Figure 1. Effect of pretreatment with MSM 100 mg/kg on serum A) 
AST and B) ALT in rats with acetaminophen induced hepatotoxicity. 
Values are mean±SEM (n=6). APAP: acetaminophen; MSM: 
Methylsulfonylmethane  
* P< 0.01 versus normal group. † P < 0.01 versus APAP group 
 
The endogenous antioxidant, GSH level in the 
hepatic tissue was decreased significantly after 
acetaminophen intoxication as compared to the 
levels measured in the normal group (P< 0.001) 
(Table 1). However, MSM pretreatment significantly 
reversed the acetaminophen-induced GSH reduction 
(P< 0.001), but the hepatic GSH level was still low 
compared to the normal group. 
Activity of hepatic SOD was presented in Table 1. 
Compared with the normal group, hepatic SOD 
activity was decreased significantly in the 
acetaminophen group (P< 0.01), indicating 
diminished enzymatic antioxidant activity in the 
tissue. Pretreatment with MSM was successful to 
maintain the SOD activity in the hepatic tissue          
(P < 0.05) close to the range of normal group. 
 
 
Figure 2. Representative photographs of liver histopathology (H & 
E, 200) in a) normal control rat, no necrosis b) acetaminophen 
intoxicated control rat and c) rat pretreated by MSM (100 mg/kg).  
 
Histopathological examination of liver sections of 
control group showed normal cellular architecture 
with distinct hepatic cells, sinusoidal spaces and 
central vein (Figure 2a). Disarrangement of normal 
hepatic cells with necrosis and destruction of central 
vein are observed in acetaminophen-intoxicated 
liver (Figure 2b). The liver sections of the rat 
pretreated in the test group (Figure 2c), showed less 
necrosis and overall less visible changes compared to 
acetaminophen control group, showing that pre-
supplementing with MSM has some protective effect 
on liver tissue. 
 
Discussion 
In the present study, acetaminophen-induced liver 
toxicity was evidenced by biochemical measurements 
and histopathological observations. Increased level of 
serum AST and ALT indicated deterioration in the 
hepatic functions due to toxic effects of APAP. 
Pretreatment with 100 mg/kg MSM for one week 
helped in attenuating the acetaminophen induced toxic 
consequences in the liver.  
The ability of MSM to mitigate APAP induced 
hepatic toxicity is partly due to its serving action as a 
sulfur donating agent for synthesis of new cysteine, a 
rate limiting precursor of GSH production (6, 16).  
Acetaminophen is a safe and effective analgesic 
when used in therapeutic doses. However, an 
overdose can induce severe hepatotoxicity (17). In 
overdose, acetaminophen is metabolized to NAPQI 
(N-acetyl-p-benzoquinoneimine) predominantly via 
hepatic cytochromes. The NAPQI-induced depletion 
of cytosolic and mitochondrial GSH leads to liver 
injury (18) which was confirmed in our study by 
concurrent increase in liver MDA indicating 
significant lipid peroxidation. The APAP-induced 
a c b 
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decrease in GSH pool was alleviated significantly by 
MSM pretreatment, which is in agreement with the 
fact that exogenous administration of antioxidants 
may influence the GSH metabolism (18). Therefore, 
MSM may play an important role in protection 
against acetaminophen intoxication by modulating 
the cellular GSH pool. It was proposed that MSM 
could acts as a source of sulfur which may induce 
new GSH synthesis (6). The ability of MSM to prevent 
GSH depletion in other oxidative conditions such as 
exercise (5, 16) or chemically induced oxidative 
stress (3) has been previously reported. 
It has been proposed that the acetaminophen 
metabolism triggers lipid peroxidation which may be 
responsible for liver injury (19). In the present 
study, a significant increase in MDA content, an index 
of lipid peroxidation, was observed. This increase is 
in parallel with reduction in liver GSH and SOD 
levels. Our data also showed that pretreatment with 
MSM significantly inhibits MDA production and 
decreases its level toward normal, implying 
decreases in lipid peroxidation and liver injury. In 
our previous studies, MSM showed anti-oxidant 
effect on acetic acid induced colitis in rats (3) and 
exercise induced oxidative stress in humans (5). In 
accordance, findings from the current study also 
showed that pretreatment with MSM may reduce 
acetaminophen induced liver damage by attenuating 
lipid peroxidation and glutathione depletion 
confirmed by histopathological observations of rat 
liver tissue.  
There are evidences that inflammatory cells such 
as neutrophils may be involved in the 
pathophysiology of the acetaminophen-induced liver 
injury (20). Myeloperoxidase is one of the most 
important oxygen-dependent enzymes in neutrophils 
which if released into local tissue or the systemic 
circulation, can induce oxidative stress, with variable 
degrees of cytotoxicity (21). It was also confirmed 
that estimation of tissue MPO activity is reliable 
indicator of inflammation (21, 22). In the current 
study, pretreatment with MSM was able to reduce 
the tissue MPO activity toward normal. Beilke et al. 
have reported that MSM is a strong suppressor of 
superoxide and hydrogen peroxide production in 
neutrophils (23).Therefore, It may be postulated that 
protective effect of MSM on liver tissue could be in 
part due its anti-inflammatory action which is in 
agreement with other studies (2, 3).  
Although the present study is the first report on 
MSM hepatoprotective effect, it has some limitations, 
which need to be addressed in ongoing 
investigations. First, the dose-dependent effect of 
MSM on acetaminophen induced hepatotoxicity in 
not explored in current study. Second, there is a need 
to address the effects of MSM on other known 
markers of oxidation and inflammation underlying 
liver damage and also there is a need to explore the 
mechanism that MSM does its effects. 
Conclusion 
Considering the low toxicity of MSM and the 
findings of the current study which illustrated that 
MSM, as a sulfur donating and antioxidant agent, 
alleviates indices of hepatic injury induced by 
acetaminophen, it is possible to suggest that MSM as 
a pretreatment agent has a potential to be 
investigated as an agent in limiting the drug-induced 
oxidative damage. 
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